-
-
-
-
-
-
-
Jaguar Health's Italian Subsidiary Napo EU Appoints Massimo Mineo General Manager
-
-
-
-
-
-
-
Jaguar Health Announces Closing of Private Placement Priced at a Premium to Market
-
-
-
-
-
-
-
Jaguar Health Announces Selection of Investment Bank and Nominated Advisor for Proposed Merger of the Dragon SPAC and Napo EU, Jaguar's Italian Subsidiary
-
-
-
-
-
-
-
Jaguar Health Signs Memorandum of Understanding with the Lead Sponsor of the Planned Dragon SPAC Pursuing Listing on AIM Italia, Providing the Dragon SPAC with Exclusivity for a Proposed Business Comb
-
-
-
-
-
-
-
Jaguar Health Announces Adjournment of Its Special Meeting of Stockholders Until Tuesday, December 22, 2020
-
-
-
-
-
-
-
Jaguar Health Refinances $10.5 Million of Secured Debt, Including an Extension of the Maturity of Such Debt from December 31, 2019 to December 31, 2020
-
-
-
-
-
-
-
RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

